Pharmaceutical Texture Analyzer — 0.01N Precision for Pharma QC.

The KHT TA-30 is a pharmaceutical texture analyzer purpose-built for pharma QC, R&D, and regulatory-compliant formulation work. It delivers 0.01N force resolution, 0.001 mm displacement accuracy, and a 0.001–40 mm/s speed range that covers every standard pharmaceutical test method — from USP <1217> tablet breaking force to EP 2.9.8 resistance to crushing, JP 6.09 disintegration correlation, and 21 CFR Part 11-compliant electronic records. Unlike general-purpose instruments repurposed from the food industry, the KHT TA-30 ships with a 30+ dosage form method library, a full IQ/OQ/PQ validation package, and transparent public pricing in the $8,000–$13,000 range — roughly half the cost of equivalent European or US brands.

Why Pharmaceutical Labs Choose the KHT TA-30

Pharmaceutical quality control does not tolerate ambiguity. When a batch release depends on a tablet breaking force measurement or a capsule rupture peak, your instrument's force resolution, data acquisition rate, and audit trail integrity define whether your data survives an FDA, EMA, or PMDA inspection. The KHT TA-30 was engineered from the ground up for this environment. Every specification, every included accessory, and every software feature answers a specific regulatory or technical requirement that a pharma QC lab must satisfy.

The first reason labs choose the KHT TA-30 is force resolution. At 0.01N, the TA-30 measures ten times finer than budget-tier instruments that publish 0.1N resolution and matches the enterprise-tier systems that cost two to four times more. For microneedle insertion studies (0.4–8N typical force window), soft gelatin capsule rupture (5–50N), and ointment spreadability (1–20N), 0.01N resolution is not a marketing number — it is the difference between a curve that reveals a formulation problem and a curve that hides it inside measurement noise.

The second reason is application breadth built on a single platform. A pharmaceutical texture analyzer is only useful if it can handle the dosage forms your lab actually develops. The TA-30 ships with a method library covering tablets (hardness, friability correlation, breaking force), hard and soft gelatin capsules (rupture, puncture, Bloom strength), semi-solids (creams, ointments, gels, suppositories), transdermal patches (180° and 90° peel, peel work, tack), injectable devices (plunger glide force, auto-injector activation), microneedle arrays (fracture force, penetration depth), and pharmaceutical packaging (blister peel, foil tear resistance, child-resistant cap torque). One instrument, one software, one audit trail — across every formulation your pipeline handles.

The third reason is compliance built in, not bolted on. 21 CFR Part 11 compliance is not an optional software upgrade on the TA-30. Electronic records, secure e-signatures, time-stamped audit trails, role-based user permissions, and SOP lock-down are standard features of the shipping software. The IQ/OQ/PQ validation package is included at delivery. USP <1217>, EP 2.9.8, JP, and 21 CFR Part 211 are referenced directly inside the method library — you do not need to write them in from scratch. This is the difference between a pharmaceutical-grade instrument and a general-purpose instrument sold into pharma.

The fourth reason is transparent pricing. The TA-30 lists at $8,000–$13,000, with configuration-dependent options published on this site. You do not need to fill out an inquiry form to see what the instrument costs. You do not need to negotiate with a regional distributor. You do not need to budget for a hidden "pharma compliance edition" that doubles your quote. What you see on the pharmaceutical texture analyzer price page is what you pay.

The fifth reason is direct engineering support. KHT is a direct-sales manufacturer, not a reseller chain. When you email the engineering team, you reach the engineering team — with a 48-hour technical response SLA written into the service agreement. Method migration from Stable Micro Systems (SMS) or Cell Instruments hardware is supported directly; we will reproduce your existing method on the TA-30 and ship a method equivalency report so your validated protocols survive the platform change.

Together, these five differentiators define the position the TA-30 occupies: a professional pharmaceutical texture analyzer at a value price, with compliance as standard, transparency as default, and specialization as the core design principle.

Core Applications: Tablet, Capsule, Gel, Ointment & Injectables

The KHT TA-30 is validated across seven primary pharmaceutical application categories, each supported by pre-loaded methods, recommended probes, and standard references. The sections below summarize the core application set; detailed protocol pages are available through the application hubs linked inline.

Solid oral dosage forms remain the single largest pharmaceutical texture testing category. The TA-30 runs USP <1217> tablet friability correlation and EP 2.9.8 resistance to crushing tests directly, using 75–100 mm parallel plates or dedicated diametral compression fixtures. Breaking force for standard tablets ranges from 5–300N depending on compression profile, well within the TA-30's 500N standard load cell. The instrument also handles capsule burst and rupture force (5–50N for hard gelatin capsules, under 30N for most soft gelatin capsules), gelatin shell Bloom strength per GB13731 and USP <1>, and film coating adhesion. For labs standardizing across tablet and capsule QC, the TA-30 consolidates what would otherwise require two dedicated instruments plus a separate Bloom gelometer. See the tablet hardness testing texture analyzer hub and the dedicated tablet hardness testing texture analyzer protocol page for method details, and the capsule hardness tester pharmaceutical page for hard capsule rupture procedures.

Semi-solid and topical formulations include creams, ointments, gels, hydrogels, lotions, pastes, and suppositories. The TA-30 supports spreadability testing with cone-and-plate or extrusion-cell fixtures, gel firmness measurement with back-extrusion rigs, hydrogel bioadhesion and mucoadhesion studies with tissue holders, suppository hardness and penetration force with cylindrical probes, and BP alginate raft strength tests with dedicated raft-measurement fixtures. Force windows typically fall between 0.1N and 50N, making 0.01N resolution essential for distinguishing formulation variants that would otherwise appear equivalent. Visit the pharmaceutical gel spreadability testing hub and the dedicated gel spreadability testing application page for method parameters.

Transdermal patches and medical tapes are the fastest-growing pharma texture testing application segment, driven by expanding pipelines in long-acting hormone therapy, nicotine replacement, and analgesic delivery. The TA-30 performs 180° peel and 90° peel tests per ASTM D903 and ASTM D1876, peel work calculation (area under force-distance curve), tack measurement, and skin-adhesion simulation at 32°C using the optional Peltier temperature plate accessory. USP <1724> is explicitly referenced in the pre-loaded methods.

Injectables, syringes, and biologics are measured with dedicated fixtures for syringe plunger extraction (glide force), injection force, auto-injector spring activation, and needle insertion force. Standards covered include ISO 11608 (needle-based injection systems) and USP <1207> (package integrity). Glide and break-loose force measurements benefit directly from 0.01N resolution because plunger stiction events are often below 0.5N.

Microneedles and novel delivery systems are an emerging area with no dedicated pharmacopoeia standard yet. The TA-30 runs microneedle array fracture force testing using flat cylindrical compression probes, individual needle compression strength studies, and penetration depth measurement in tissue-simulant skin models. The 0.001 mm displacement resolution and 0.001 mm/s minimum speed are both critical here: microneedle failure modes occur over displacement ranges of 10–50 microns and must be captured at slow insertion speeds to simulate in-vivo application.

Pharmaceutical packaging testing on the TA-30 includes blister pack peel-off force, aluminum foil tear resistance, child-resistant cap open/close torque (with the optional torque fixture), and packaging film puncture resistance per USP <661> and ISO 15747.

Advanced and emerging formulations — 3D-printed oral dosage forms, biodegradable implants, drug-eluting devices, and nanomedicines — use customizable method slots in the software. ISO 10993, ASTM F1635, and 21 CFR Part 880 references are supported for implant and device-adjacent testing.

Across all seven categories, the TA-30 uses a universal probe mount compatible with third-party tooling, which eliminates the proprietary-probe lock-in that inflates long-term costs on some competing platforms.

Technical Specifications: 0.01N Resolution vs. Competitors

The single most important specification for a pharmaceutical texture analyzer is force resolution. At 0.01N, the KHT TA-30 exceeds the typical budget-brand resolution (around 0.1N) by a factor of ten and matches enterprise-brand resolution at roughly half the cost. The full specification table below summarizes the KHT TA-30 core metrics against the two reference competitor tiers the pharmaceutical market recognizes.

Technical Specifications

How KHT TA-30 Compares

The KHT TA-30 occupies the "professional pharmaceutical specialist × value pricing × compliance built-in × transparent pricing" quadrant that no other brand currently fills. This is not a marketing claim; it is an observable gap in the published specifications and pricing structures of every major competitor.

For a deeper side-by-side including Stable Micro Systems and Cell Instruments benchmarks, see the dedicated pharmaceutical texture analyzer specifications comparison page.

Regulatory Compliance: USP 1217, EP 2.9.8, JP, 21 CFR Part 11

Compliance is not a feature you add to a pharmaceutical texture analyzer — it is the reason you buy one instead of a general-purpose universal testing machine. The KHT TA-30 addresses compliance across four layers: pharmacopoeia method compliance, electronic records compliance, installation and performance qualification, and quality system certification.

Pharmacopoeia method compliance covers the test methods referenced in USP, EP, JP, BP, and Chinese Pharmacopoeia chapters. The TA-30 ships with pre-loaded methods corresponding to USP <1217> (tablet friability), USP <1> (disintegration correlation via physical testing), USP <1207> (package integrity), USP <1724> (semisolid drug products), EP 2.9.1 (disintegration of tablets and capsules), EP 2.9.8 (resistance to crushing — tablets), JP 6.09 (disintegration), and BP alginate raft strength. Each pre-loaded method defines probe geometry, test speed, trigger force, target distance or rupture criterion, and output metrics exactly as specified by the pharmacopoeia. Running a compliant test becomes a one-click operation rather than a method development exercise. See the pharmaceutical testing standards hub for the full compliance matrix.

Electronic records compliance under 21 CFR Part 11 is the single most-requested compliance feature by FDA-regulated laboratories. The KHT TA-30 software satisfies every Part 11 subpart: (a) complete audit trail of every data-affecting action with time, user, and before/after value; (b) secure, traceable electronic signatures tied to authenticated user accounts; (c) role-based permission tiers (Operator, Reviewer, Administrator, QA); (d) SOP lock-down mode that prevents parameter modification during QC runs; (e) tamper-evident data storage with cryptographic checksums; and (f) exportable audit reports formatted for FDA inspection. Unlike some competing platforms, these capabilities are not sold as a paid "advanced edition" — they are standard in the shipping software.

Installation and performance qualification under GMP requires documented IQ, OQ, and PQ protocols. The TA-30 ships with a complete validation package: installation qualification protocol and worksheet, operational qualification test procedures (force accuracy across the load cell range, displacement accuracy, speed accuracy, repeatability), performance qualification study template with statistical acceptance criteria, NIST-traceable calibration certificate, and a calibration maintenance schedule. Documents are provided in editable format so your QA team can incorporate them directly into your site-specific validation master plan.

Quality system certifications include CE marking for EU market access, GMP-validated manufacturing for the instrument itself, and USP-compatible material specifications for fixtures that contact dosage forms. This stack covers the regulatory envelope required by pharma customers in the US, EU, Japan, and export markets. Compare this to USP 1217 tablet hardness and EP 2.9.8 tablet resistance to crushing standard-specific pages for implementation details.

One practical consequence of building compliance in at the platform level: your validation effort on the TA-30 is shorter. A typical site brings a validated TA-30 into routine QC use within two to four weeks of delivery. For CRO and CDMO environments where validation cycles drive revenue timing, this is a material cost advantage.

Probes, Accessories & Software — Everything in One Package

A pharmaceutical texture analyzer is a system, not a standalone instrument. The KHT TA-30 is sold as a configured package so that a QC lab can run validated tests on day one without assembling a second purchase order for probes, fixtures, or a compliance software license.

Standard probe set (included with every TA-30) covers the high-frequency pharmaceutical tests: a 75 mm parallel plate for tablet diametral compression (USP <1217>, EP 2.9.8), a 6 mm flat cylindrical probe for microneedle and general compression, a 2 mm spherical probe for puncture and capsule rupture, a 36 mm cone and plate assembly for gel and cream consistency, a 25 mm back-extrusion rig for ointment and paste evaluation, and a 180° peel jig for transdermal patch work. A universal probe mount means any standard metric-threaded probe — whether from KHT, a third-party supplier, or an existing SMS tooling library — can be used without adapters.

Optional application packs extend coverage into specialized testing: the Injection Pack (syringe glide rig, auto-injector activator, needle insertion holder) for ISO 11608 testing; the Transdermal Pack (Peltier temperature plate for 32°C skin simulation, 90° peel fixture, tack plate) for USP <1724> work; the Packaging Pack (blister peel rig, child-resistant cap torque fixture, foil puncture plate) for USP <661> testing; and the Bloom Pack (Bloom plunger and cell) for gelatin shell raw material QC per GB13731 and BP standards.

Software is included at no additional license cost. The KHT Texture Suite provides the method library, live force-displacement curve view, automatic TPA calculation (hardness, cohesiveness, springiness, chewiness, gumminess, adhesiveness, resilience), statistical reporting across sample batches, multi-format export (CSV, PDF, JSON, XLSX), LIMS integration via REST API, and the full 21 CFR Part 11 compliance feature set described above. Software updates and bug fixes are free for the life of the instrument. See the pharmaceutical texture analyzer software page for the complete feature inventory.

Accessory pricing is transparent. Every probe, fixture, and application pack is priced on the pharmaceutical texture analyzer probes page. There is no "contact us for pricing" anywhere in the accessory catalog. Compared to proprietary-ecosystem competitors where individual probes can cost $200–$2,000 each with no published list price, this removes a long-term TCO risk that often exceeds the instrument purchase price over a five-year use cycle.

A fully configured TA-30 with the standard probe set, software, IQ/OQ/PQ package, 2-year warranty, and one year of remote support lists at $8,000–$13,000 depending on load cell and optional feature selection. For a detailed cost breakdown and a five-year total-cost-of-ownership comparison against enterprise brands, see the pharmaceutical texture analyzer price guide.

Who Buys the KHT TA-30

The KHT TA-30 is designed for six primary customer segments, each of which has a different procurement driver and a different point of technical sensitivity.

Pharmaceutical QC laboratories buy the TA-30 as a primary batch-release instrument for tablet hardness, capsule integrity, and topical consistency testing. The compliance stack (21 CFR Part 11, IQ/OQ/PQ, USP/EP method library) is non-negotiable, and the direct pricing and IQ/OQ/PQ inclusion shortens their qualification timeline meaningfully.

Pharmaceutical R&D laboratories buy the TA-30 for formulation screening, excipient evaluation, and process development work. The 0.01N force resolution and 30+ method library let formulation scientists distinguish between formulation variants that a 0.1N-resolution instrument would flatten into noise. R&D groups value the speed range (0.001–40 mm/s) because microneedle and bioadhesion studies require the low end while packaging and tensile work requires the high end.

Contract research organizations (CROs) and CDMOs buy the TA-30 for multi-client flexibility. The SOP lock-down feature supports per-client test-method isolation. The universal probe mount removes the risk of a client-specific probe ecosystem lock-in. Transparent pricing simplifies project-based cost allocation.

Academic pharmaceutical departments buy the TA-30 for teaching and research. The price point fits grant budgets, and the 30+ method library gives graduate students a working reference point for formulation studies without a senior scientist developing methods from scratch.

Generic drug manufacturers buy the TA-30 for bioequivalence-supporting physical characterization work. The ability to reproduce a reference listed drug's mechanical profile within a validated, Part 11-compliant data trail is a specific regulatory value.

Biotech startups buy the TA-30 when they need pharmaceutical-grade instrumentation without enterprise-grade capital expenditure. The transparent $8,000–$13,000 price tier is accessible at the pre-Series B stage, which is typically when texture analyzer procurement first becomes unavoidable.

What You Get With Every KHT TA-30

Every KHT TA-30 pharmaceutical texture analyzer shipment includes: the TA-30 instrument with your specified standard load cell, the standard probe set described above, the KHT Texture Suite software with 21 CFR Part 11 compliance features enabled, the 30+ dosage form method library, the complete IQ/OQ/PQ validation package, a NIST-traceable calibration certificate, a 2-year standard warranty, one year of remote technical support with a 48-hour response SLA, free software updates for the life of the instrument, and free access to the KHT Pharmaceutical Training Library covering tablet, capsule, semi-solid, patch, and microneedle test methodologies. Install support via remote video walkthrough is complimentary; on-site installation is available at published flat-rate pricing.

Request a Quote for the KHT TA-30

Pricing on the KHT TA-30 pharmaceutical texture analyzer is transparent and published at $8,000–$13,000 depending on configuration. Every quote includes the complete IQ/OQ/PQ validation package, the 30+ dosage form method library, the 21 CFR Part 11-compliant software, the standard probe set, and 2-year warranty coverage.

Request a quote and expect a response within 24 hours. Technical pre-sales questions receive engineering answers within 48 hours under our direct-support SLA. For method migration from an existing Stable Micro Systems, Cell Instruments, or other platform, include your current method parameters in the inquiry and we will return a method-equivalency plan with the quote. Contact KHT Instrument to start.